(Q51103360)

29 March 2018

title

Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis? (English)

1 reference

29 March 2018

main subject

liver cirrhosis

0 references

hepatocellular carcinoma

1 reference

11

1 reference

29 March 2018

author name string

Franco Trevisani

1

1 reference

29 March 2018

Valentina Santi

2

1 reference

29 March 2018

Annagiulia Gramenzi

3

1 reference

29 March 2018

Maria Anna Di Nolfo

4

1 reference

29 March 2018

Paolo Del Poggio

5

1 reference

29 March 2018

Luisa Benvegnù

6

1 reference

29 March 2018

Gianludovico Rapaccini

7

1 reference

29 March 2018

Fabio Farinati

8

1 reference

29 March 2018

Marco Zoli

9

1 reference

29 March 2018

Franco Borzio

10

1 reference

29 March 2018

Eugenio Caturelli

12

1 reference

29 March 2018

Mauro Bernardi

13

1 reference

29 March 2018

Italian Liver Cancer Group

14

1 reference

29 March 2018

language of work or name

English

0 references

publication date

7 July 2007

1 reference

29 March 2018

The American Journal of Gastroenterology

published in

1 reference

29 March 2018

volume

102

1 reference

29 March 2018

issue

11

1 reference

29 March 2018

page(s)

2448-57; quiz 2458

1 reference

29 March 2018

Primary liver cancer: worldwide incidence and trends

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01395.X

Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01395.X

Screening for hepatocellular carcinoma in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01395.X

Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01395.X

Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01395.X

Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01395.X

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01395.X

Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01395.X

Transection of the oesophagus for bleeding oesophageal varices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01395.X

Hepatocellular carcinoma: is surveillance cost effective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01395.X

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01395.X

A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01395.X

Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01395.X

Randomized control trials on chemoembolization for hepatocellular carcinoma: is there room for new studies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01395.X

Screening in liver disease: report of an AASLD clinical workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01395.X

A biomathematical approach to clinical tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01395.X

Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01395.X

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01395.X

Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01395.X

Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01395.X

Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01395.X

10.1111/J.1572-0241.2007.01395.X

21 January 2018

Identifiers

DOI

1 reference

29 March 2018

1 reference

29 March 2018